NCT06634875 2025-04-22Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)Buzzard PharmaceuticalsPhase 2 Recruiting20 enrolled
NCT04121442 2024-08-06Isunakinra Alone and in Combination With a PD-1/PD-L1 Inhibitor in Patients With Solid TumorsBuzzard PharmaceuticalsPhase 1/2 Completed15 enrolled